JPH0539299A - 新規なカルシトニン - Google Patents

新規なカルシトニン

Info

Publication number
JPH0539299A
JPH0539299A JP3249322A JP24932291A JPH0539299A JP H0539299 A JPH0539299 A JP H0539299A JP 3249322 A JP3249322 A JP 3249322A JP 24932291 A JP24932291 A JP 24932291A JP H0539299 A JPH0539299 A JP H0539299A
Authority
JP
Japan
Prior art keywords
peptide
gln
thr
leu
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP3249322A
Other languages
English (en)
Japanese (ja)
Inventor
Yoshio Takei
祥郎 竹井
Akiyoshi Takahashi
明義 高橋
Yuichi Sasayama
雄一 笹山
Masaharu Takigawa
正春 滝川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Steel Corp
Original Assignee
Sumitomo Metal Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Metal Industries Ltd filed Critical Sumitomo Metal Industries Ltd
Priority to JP3249322A priority Critical patent/JPH0539299A/ja
Priority to PCT/JP1992/000706 priority patent/WO1992021700A1/ja
Priority to US07/952,735 priority patent/US5440012A/en
Priority to EP92910720A priority patent/EP0541822B1/en
Priority to ES92910720T priority patent/ES2073924T3/es
Priority to DE69202136T priority patent/DE69202136T2/de
Publication of JPH0539299A publication Critical patent/JPH0539299A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP3249322A 1991-05-31 1991-09-27 新規なカルシトニン Withdrawn JPH0539299A (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP3249322A JPH0539299A (ja) 1991-05-31 1991-09-27 新規なカルシトニン
PCT/JP1992/000706 WO1992021700A1 (en) 1991-05-31 1992-05-29 Novel calcitonin, and production and use thereof
US07/952,735 US5440012A (en) 1991-05-31 1992-05-29 Calcitonin and method for the preparation and use thereof
EP92910720A EP0541822B1 (en) 1991-05-31 1992-05-29 Novel calcitonin, and production and use thereof
ES92910720T ES2073924T3 (es) 1991-05-31 1992-05-29 Nueva calcitonina y metodo para la preparacion y uso de la misma.
DE69202136T DE69202136T2 (de) 1991-05-31 1992-05-29 Neuartiges calcitonin, und seine herstellung und verwendung.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP12969591 1991-05-31
JP3-129695 1991-05-31
JP3249322A JPH0539299A (ja) 1991-05-31 1991-09-27 新規なカルシトニン

Publications (1)

Publication Number Publication Date
JPH0539299A true JPH0539299A (ja) 1993-02-19

Family

ID=26465007

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3249322A Withdrawn JPH0539299A (ja) 1991-05-31 1991-09-27 新規なカルシトニン

Country Status (6)

Country Link
US (1) US5440012A (enExample)
EP (1) EP0541822B1 (enExample)
JP (1) JPH0539299A (enExample)
DE (1) DE69202136T2 (enExample)
ES (1) ES2073924T3 (enExample)
WO (1) WO1992021700A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571788A (en) * 1991-12-09 1996-11-05 Ciba-Geigy Corporation Stable calcitonin pharmaceutical compositions
US5962270A (en) 1996-02-06 1999-10-05 Bionebraska, Inc. Recombinant preparation of calcitonin fragments and use thereof in the preparation of calcitonin and related analogs
GB9610281D0 (en) * 1996-05-16 1996-07-24 Ralston Stuart H Diagnostic method and apparatus
CA2320117A1 (en) * 1998-02-12 1999-08-19 Emory University Sphingolipid derivatives and their methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4898009A (enExample) * 1972-03-31 1973-12-13
US4397780A (en) * 1982-02-12 1983-08-09 Armour Pharmaceutical Company Leucine22 -calcitonin

Also Published As

Publication number Publication date
DE69202136T2 (de) 1995-11-30
EP0541822B1 (en) 1995-04-19
ES2073924T3 (es) 1995-08-16
US5440012A (en) 1995-08-08
WO1992021700A1 (en) 1992-12-10
DE69202136D1 (de) 1995-05-24
EP0541822A1 (en) 1993-05-19
EP0541822A4 (enExample) 1994-01-19

Similar Documents

Publication Publication Date Title
US7186694B2 (en) Leptin-related peptides
Kemp et al. Parathyroid hormone-related protein of malignancy: active synthetic fragments
ES2534434T3 (es) Composiciones y métodos de uso de péptidos proislotes y análogos de los mismos
EP0246753B1 (en) Fibroblast growth factor antagonists
EP0305401B1 (en) Combinations having synergistic growth hormone releasing activity and methods for use thereof
CN101678084B (zh) 未酰基化的生长素释放肽作为治疗代谢紊乱中的治疗剂
JPS63500036A (ja) 線維芽細胞発育因子
JPH10330397A (ja) サイトカイン調節剤およびサイトカインレベルの変化に関連する病状および状態における使用方法
JPH04504858A (ja) 肝臓特異性インシュリン類似体
CA2266416C (en) Insulin c-peptides
US6756205B2 (en) Methods for inhibiting CGRP binding
JPH0720993B2 (ja) 生長因子
JPH10502360A (ja) ヒトインターロイキン４のアンタゴニストもしくは部分的アゴニストとして用いられる新規ｈＩＬ−４突然変異蛋白質
PT99118B (pt) Processo de preparacao de protease de interleucina 1b,de inibidores da protease de interleucina 1b e de composicoes farmaceuticas
JPS61118400A (ja) 成長ホルモン放出性因子類似体及びその製造方法
US4734399A (en) Growth hormone releasing factor analogs
JPH02504274A (ja) ヒトインシユリンアナログ類
TW469273B (en) Bone stimulating factor
JPH0539299A (ja) 新規なカルシトニン
WO1992014834A1 (en) Insulin-like growth factor binding protein
JP2004008027A (ja) ｃＡＭＰの産生活性を有する新規ペプチド
JP2005082489A6 (ja) 新規な摂食促進ペプチド、新規な成長ホルモン分泌促進ペプチド
JP2005082489A (ja) 新規な摂食促進ペプチド、新規な成長ホルモン分泌促進ペプチド
US20030050434A1 (en) Peptide
WO1994026292A1 (en) Amylin antagonists and agonists

Legal Events

Date Code Title Description
A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 19981203